The Institute of Cancer Sciences (ICS) at the University of Glasgow is seeking to appoint a Professor of Molecular Pathology of Cancer, to lead the development of the Molecular Pathology of Cancer Unit and establish a major programme of research in this area. This post is part of a strategic expansion within the ICS, in partnership with the Beatson Institute of Cancer Research, that includes the completion of a new research complex providing space for 400 research staff and commitment to recruit up to ten additional faculty. This post comes with generous start-up funding, new laboratory space and access to state of the art facilities.
Applications are invited from candidates of international standing with an appropriate record of academic achievement, who wish to develop and maintain their own research programme while also taking broader responsibility for the development and direction of the Molecular Pathology of Cancer Unit. Qualified clinical and non-clinical applicants are encouraged to apply.
This role reports to the Director of Institute and is a key member of the Institute’s Management Group.
• To provide world-class leadership for the Molecular Pathology of Cancer Unit, building a cohesive programme of world-class cancer research that complements the strategy and existing programmes within the ICS. Resources are available to expand this Unit, and the Chair of Molecular Pathology of Cancer will take responsibility for the recruitment, management and development the other Group Leaders within the Unit, in collaboration with the Director and the Institute Management Group.
• To build an internationally competitive and externally grant funded research program in molecular pathology of cancer research, publishing high impact research papers, communicating of this work at international meetings/symposia and participating in review and advisory groups and panels.
• To collaborate with scientific and clinical research groups in Glasgow and beyond to promote the translation of basic cancer research to patient benefit.
Main Duties and Responsibilities
1. To provide outstanding academic leadership to the Unit, by providing a coherent vision for research and postgraduate training and by inspiring the highest standards of research by Institute staff. The post-holder will lead the development and management of internationally recognised research within the Molecular Pathology of Cancer Unit. To play a leading role in raising the profile and contribute substantially to the Institute’s, the College’s and the University’s recognition in the field.
2. To develop and lead an internationally recognised research programme in molecular pathology of cancer research, and to develop the resources to support this work by recruiting and maintaining a high performance research group and securing external funding through grants and fellowships.
3. For a practicing clinician, it will be possible to arrange a limited number of clinical sessions at consultant level within the NHS and the post holder would be expected to have demonstrated the level of clinical competence required to make clinical decisions. However, the post is predominantly research oriented, and the job plan will be flexible to ensure that it reflects the essential requirement to run an internationally competitive research group.
4. To contribute fully to developing and enhancing the research profile of the ICS by establishing a track record of publications of international quality in leading high impact journals, contribute to international meetings and taking part in review and granting panels at the national/international level as appropriate.
5. To undertake appropriate administrative responsibility for the Molecular Pathology of Cancer Unit, including selection, assessment, mentoring and development of post-doctoral and pre-doctoral research scientists. To contribute to other aspects of administration within the ICS as required by the Director.
6. To contribute actively in developing the strategy, priorities, direction and success of the ICS, as part of the Institute Management Group.
7. Develop and lead the Unit’s international academic profile and enhance its international recruitment and partnership development.
8. Support and lead collaborative developments in research, teaching and internationalization both within the College and across the University contributing to Graduate School activities designed to broaden the skills and experience of postgraduate students
9. Take full financial responsibility and control of the Unit’s devolved budgets and agree the financial, strategic and operational plans in partnership with its staff and the Director of Institute; allocate resources accordingly, with clear objectives, targets and associated measurements.
10. Ensure that the Unit and its members comply with the University’s policies on research quality and conduct and the requirements of all relevant regulatory bodies.
11. Ensure that all University policies and procedures are communicated to and complied with by all members of the Group through the management line and that good employee relations are maintained.
Knowledge, Qualifications, Skills and Experience
A1. Higher Degree. PhD or MD & MBChB or equivalent for clinical candidates
A2 Certificate of Completion of Training and Specialist qualification in Pathology (FRCPath or equivalent) entered on the General Medical Council Specialist Register to practice Pathology in the UK. (only applicable for clinincally qualified applicants intending to carry out clinical work).
B1. Typically more than 10 years research experience; normally at least 3 in a senior academic management role.
B2. Significant international reputation for academic excellence in research, evidenced through a sustained and outstanding publication record in high impact journals.
B3. Ability to import an activate area of research in molecular pathology of cancer that is appropriate to the research strategy of the ICS.
B4. Experience of conducting and leading research across national boundaries.
B5. Successful and sustained record of winning substantial research income from major granting bodies
B6. A successful track record of supervising research and/or clinical staff, and to work constructively with staff at all levels
B7. First class communication and interpersonal skills, and a proven ability to lead an academic team.
Specific aptitude and abilities Essential:
D1. A strategic thinker with a demonstrable track record in developing sustainable research
D2. Ability to combine and integrate the skills and expertise of highly motivated staff into multi disciplinary teams, developing and building upon existing collaborations as well as creating/facilitating new opportunities.
D3. Ability to engage a range of internal and external stakeholders to collaborate in identifying problems and appropriate solutions, within agreed timetables and budgets.
D4. A thorough awareness of research ethics issues.
D5. A collegiate manager who can play a full role in the management of the Institute.
All cancer research at Glasgow University comes under the umbrella of the Institute of Cancer Sciences. Prof Karen Vousden is the first Director of the Institute of Cancer Sciences and together with senior colleagues is responsible for formulation of strategic directions and setting research priorities. It is expected that candidates would be able to bring additional strengths and collaborate with those already in existence and make a major contribution to future strategic planning. Candidates can access information on our existing research through our websites (see below) –and paper version of the Beatson Institute for Cancer Research report can be obtained on request.
The Chair in Molecular Pathology will head up a new unit of Molecular Pathology within Pathology and interact closely with The Head of Pathology. There are also plans to create a Senior Lecturer positions within Molecular Pathology and the Chair in Molecular Pathology will lead the development of this Unit.
This Chair is essential to our future focus on developing a Translational Medical Research Centre for Cancer and to act as the bridge between the new BWOSCC, the Beatson Institute and Pathology. The creation of synergies between clinicians involved in the management of cancer and basic scientists is a key challenge and this new initiative in Molecular Pathology will establish interfaces that will facilitate both translational research, but also an environment for training future clinical scientists.
The post will be based at the new building (to be completed in August 2012) at Garscube alongside the Beatson Institute for Cancer Research for the research laboratories and at the appropriate clinical site for clinical pathology. New pathology laboratories are being built at the Southern General Hospital and it is predicted that all clinical pathology services for Glasgow and Clyde will be run from there in 2012. There will be a unified clinical Molecular Pathology Service with Molecular Genetics in the new pathology laboratories together with a centralised Biorepository. The new unit of Molecular Pathology will have an important role in linking with the service laboratories for research and development.
Within the new unit there is the opportunity to bring together a number of activities and staff to have a strong focus on molecular pathology. Major synergies have already been built with other teams in the University to ensure that the ICS is truly interdisciplinary. A key role for this appointee is to build on the strengths in the University in engineering, nanotechnology, bioinformatics and systems biology and to link this with the cancer strategy.
http://www.gla.ac.uk/departments/electronicsandelectricalengineering/, http://www.gla.ac.uk/faculties/fbls/functionalgenomicsfacility/, http://www.gla.ac.uk/faculties/fbls/systemsbiology/,
Further information on the ICS, the new Southern General Hospital Laboratory build and the Biorepository will be provided to applicants on request.
Planning and organising
Internal / external relationships
Additional Department/Faculty Information
Pathology is a within the Institute of Cancer Sciences in the College of Medical, Veterinary and Life Sciences. http://www.gla.ac.uk/researchinstitutes/cancersciences/
Further Information/ Informal Enquiries
The appointment will be subject to the whole powers and conditions of any Act of Parliament, Ordinances, and Law affecting the University. Subject to such Acts, the Professor will hold office until the end of the academic year in which he or she attains the age of 65 years. The appointment is a whole-time appointment, the Professor undertaking to accept paid outside work only with the prior consent of the University Court. This provision does not apply to examinerships and such other appointments as are incidental to the ordinary course of University business.
Salary will be within the professorial range and subject to negotiation.
The successful applicant (if aged under 60) will be eligible to join the Universities’ Superannuation Scheme. Further information regarding this scheme is available from the Superannuation Officer, who is also prepared to advise on questions relating to the transfer of superannuation benefits.
All research and related activities, including grants, donations, clinical trials, contract research, consultancy and commercialisation are required to be managed through the University’s relevant processes (e.g. contractual and financial), in accordance with the University Court’s policies.
Relocation assistance will be provided where appropriate.
|Click here to apply for this job|